MIRM – mirum pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD's The Liver Meeting [Yahoo! Finance]
Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $66.00 price target on the stock.
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at Citigroup Inc. from $65.00 to $68.00. They now have a "buy" rating on the stock.
Form SC 13G/A Mirum Pharmaceuticals, Filed by: BIOTECHNOLOGY VALUE FUND L P
Form 4 Mirum Pharmaceuticals, For: Nov 08 Filed by: Quan Joanne
Form 4 Mirum Pharmaceuticals, For: Nov 08 Filed by: BJERKHOLT ERIC
Form 4 Mirum Pharmaceuticals, For: Nov 08 Filed by: Peetz Christopher
Form SC 13G/A Mirum Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.